U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 20

1.

Subtype-dependent prognostic relevance of an interferon-induced pathway metagene in human node negative breast cancer

(Submitter supplied) We identified and validated the pivotal role for a metagene containing IFN-induced genes in association to higher metastatic potential as a function of the specific molecular subtype
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL6884
123 Samples
Download data: TXT
Series
Accession:
GSE37181
ID:
200037181
2.

Phosphatome profiling of estrogen receptor negative breast cancer

(Submitter supplied) Purpose: To characterize the expression of phosphatases in estrogen receptor negative breast cancer Little is known about the role of phosphatases in the major estrogen receptor negative breast cancer phenotypes (i.e. those overexpressing ERBB2 and the triple negative). We carried out microarray phosphatome profiling in 41 estrogen receptor negative (ER-) breast cancer patients (as determined by immunohistochemistry (IHC)) containing both ERBB2+ and ERBB2- in order to characterize the differences between these groups by Statistical Analysis of Microarrays (SAM). more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL4133
41 Samples
Download data: TXT
Series
Accession:
GSE51999
ID:
200051999
3.

Expression data from paired matched breast cancer Fine needle aspiration (FNA) or Core needle biopsies (CBX)

(Submitter supplied) Paired FNA and CBX specimens were prospectively collected from 37 breast cancers before any systemic therapy during a biomarker discovery study at The University of Texas M. D. Anderson Cancer Center. We identified 293 probe sets overexpressed in core biopsies; these included five highly coexpressed gene clusters (metagenes) corresponding to immune functions and extracellular matrix components. We compared gene expression profiles of pairs of fine-needle (stroma-poor) and core-needle (stroma-rich) biopsies from 37 cancers to identify stroma-associated genes
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL96
74 Samples
Download data: CEL, TXT
Series
Accession:
GSE32518
ID:
200032518
4.

Breast Cancer Gene Expression Data from Frankfurt Series

(Submitter supplied) Pooling of microarray datasets seems to be a reasonable approach to increase sample size when a heterogeneous disease like breast cancer is concerned. Different methods for the adaption of datasets have been used in the literature. We have analyzed influences of these strategies using a pool of 3,030 Affymetrix U133A microarrays from breast cancer samples. We present data on the resulting concordance with biochemical assays of well known parameters and highlight critical pitfalls. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL96
218 Samples
Download data: CEL
Series
Accession:
GSE4611
ID:
200004611
5.

The humoral immune system has a key prognostic impact in node-negative breast cancer

(Submitter supplied) Estrogen receptor (ER) expression and proliferative activity are established prognostic factors in breast cancer. In a search for additional prognostic motives we analyzed the gene expression patterns of 200 tumors of patients who were not treated by systemic therapy after surgery using a discovery approach. After performing hierarchical cluster analysis, we identified co-regulated genes related to the biological process of proliferation, steroid hormone receptor expression, as well as B cell and T cell infiltration. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL96
200 Samples
Download data: CEL
Series
Accession:
GSE11121
ID:
200011121
6.

Gene expression of breast cancer cell lines treated with conditioned medium derived from NAF and CAF

(Submitter supplied) We treated nine lines of breast cancer cells with conditioned medium derived from NAF and CAF to study the paracrine interaction beetween stroma and tumor. Gene expression profiles for breast cancer cell lines are reported after 72h of treatment with conditioned medium derived from NAF and CAF or with control media.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL10558
87 Samples
Download data: TXT
Series
Accession:
GSE70884
ID:
200070884
7.

FinHER trial : Patients with human epidermal growth factor receptor 2 (HER2)–positive breast cancer

(Submitter supplied) The FinHER trial is a multicentre phase 3 randomised adjuvant breast cancer trial that enrolled 1010 patients. The women were randomly assigned to receive three cycles of docetaxel or vinorelbine, followed by three cycles of fluorouracil, epirubicin, and cyclophosphamide.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL13667
203 Samples
Download data: CEL
Series
Accession:
GSE65095
ID:
200065095
8.

Expression Profiles of Breast Tumors from Singapore and Europe

(Submitter supplied) To facilitate a better understanding of the molecular heterogeneity of breast cancer and to uncover gene-survival associations that segregate with distinct molecular subtypes, we recently compiled a meta-analytical database of over 2,000 human breast tumor expression profiles variously annotated for clinical and pathological variables and derived from various institutions worldwide. This database was utilized for the breast tumor study cited below: Nagalla, et. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL96
139 Samples
Download data: CEL, TXT
Series
Accession:
GSE45255
ID:
200045255
9.

Molecular profiling of ERBB2-amplified breast cancers

(Submitter supplied) 15-25% of breast cancers (BC) show ERBB2-amplification and overexpression of the encoded ERBB2 tyrosine kinase receptor. They are associated with a poor prognosis but can benefit from targeted therapy. A better knowledge of these BCs may help understand their behavior and design new therapeutic strategies. In this study, we defined the high resolution genome and gene expression profiles of 54 ERBB2-amplified BCs using 244K oligonucleotide array-comparative genomic hybridization and whole-genome DNA microarrays. more...
Organism:
Homo sapiens
Type:
Expression profiling by array; Genome variation profiling by array
Platforms:
GPL9128 GPL570
109 Samples
Download data: CEL, TXT
Series
Accession:
GSE17907
ID:
200017907
10.

Mir-30e* is an independent subtype-specific prognostic marker in breast cancer

(Submitter supplied) Both gene and miRNA expression patterns separately correlate with survival in breast cancer suggesting that the development of models using both miRNAs and gene markers might improve their prediction performance. In this study miRNAs significantly associated with development of distant metastasis were identified and further investigated and validated in the publicly available dataset from the METABRIC. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL8179
123 Samples
Download data: TXT
Series
Accession:
GSE59829
ID:
200059829
11.

A Clinically Relevant Gene Signature in Triple-Negative and Basal-Like Breast Cancer

(Submitter supplied) Current prognostic gene expression profiles for breast cancer mainly reflect proliferation status and are most useful in ER-positive cancers. Triple-negative breast cancers (TNBCs) are clinically heterogeneous, and prognostic markers and biology-based therapies are needed to better treat this disease. We assembled Affymetrix gene expression data for 579 TNBCs and performed unsupervised analysis to define metagenes that distinguish molecular subsets within TNBC. more...
Organism:
Homo sapiens
Type:
Expression profiling by array; Third-party reanalysis
Platform:
GPL96
67 Samples
Download data: CEL, TXT
Series
Accession:
GSE31519
ID:
200031519
12.

Rapamycin treatment of MDA-MB-468 breast cancer cell line and MDA-MB-468 xenografts

(Submitter supplied) Mammalian target of rapamycin (mTOR) is a serine/threonine kinase involved in multiple intracellular signaling pathways promoting tumor growth. mTOR is aberrantly activated in a significant portion of breast cancers and is a promising target for treatment. Rapamycin and its analogues are in clinical trials for breast cancer treatment. Patterns of gene expression (metagenes) may also be used to simulate a biologic process of effects of a drug treatment. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
18 Samples
Download data: CEL
Series
Accession:
GSE18571
ID:
200018571
13.

Prognostic value of gene signatures and proliferation in lymph node negative breast cancer

(Submitter supplied) Analyses whether, and if so, gene expression can add prognostic information in the subgroups of patients with tumours with low or high proliferative activity. As proliferation measured with MAI and PPH3 has repeatedly been shown to be the best prognosticator in node-negative breast cancer (high sensitivity, little overtreatment).
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL6884
94 Samples
Download data: TXT
Series
Accession:
GSE46563
ID:
200046563
14.

Real-time quantitative PCR analysis of hormone-receptor-negative primary breast tumors

(Submitter supplied) Total RNA was extracted from FFPE samples of 139 chemotherapy-naïve hormone-receptor-negative breast cancers pooled from three sample sources and assayed for the expression of 21 genes within two previously reported microarray-derived prognostic signatures in 6 RT-PCR multiplexes.
Organism:
Homo sapiens
Type:
Expression profiling by RT-PCR
Platform:
GPL17831
139 Samples
Download data: TXT
Series
Accession:
GSE51630
ID:
200051630
15.

Expression data from fine-needle aspiration biopsies of breast cancer metastases from different anatomical sites

(Submitter supplied) Breast cancer molecular subtypes preferentially metastasize to specific organs and the anatomical location of the metastasis is associated with the length of survival post-recurrence. We used microarrays to provide a detailed characterization of breast cancer site-specific metastases with particular focus on identifying genes predictive of breast cancer liver metastatic proprnsity
Organism:
Homo sapiens
Type:
Expression profiling by array
Dataset:
GDS4761
Platform:
GPL10379
91 Samples
Download data: CEL, TXT
Series
Accession:
GSE46141
ID:
200046141
16.
Full record GDS4761

Breast cancer metastases from different anatomical sites: fine-needle aspiration biopsies

Analysis of breast cancer (BC) metastases from different anatomical sites collected prior to treatment. The anatomical location of the metastatic lesion is associated with length of survival post-recurrence. Results provide insight into molecular mechanisms underlying BC site-specific metastases.
Organism:
Homo sapiens
Type:
Expression profiling by array, transformed count, 7 tissue sets
Platform:
GPL10379
Series:
GSE46141
91 Samples
Download data: CEL
17.

Molecular characteristics and metastasis predictor genes of triple-negative breast cancer

(Submitter supplied) This microarray dataset contains 51 triple-negative breast cancers with clinical and recurrence information for at least 3 years of follow-up and 106 luminal breast cancers (reanalyzed data from Series GSE24124, GSE9309, and GSE17040). A novel set of 45-gene signature that was statistically predictive of distant metastasis recurrence for triple-negative breast cancer was identified in this study.
Organism:
Homo sapiens
Type:
Expression profiling by array; Third-party reanalysis
Platform:
GPL7264
51 Samples
Download data: TXT
Series
Accession:
GSE33926
ID:
200033926
18.

Prognostic significance of interferon-γ and its signaling pathway in early breast cancer depends on the molecular subtypes

(Submitter supplied) Interferons are crucial for adaptive immunity and play an important role in the immune landscape of breast cancer. Using microarray-based gene expression analysis, we examined the subtype specific prognostic significance of interferon-γ (IFN-γ) as a single gene as well as an IFN-γ signature covering the signaling pathway in 461 breast cancer patients. Prognostic significance of IFN-γ as well as the IFN-γ signature for metastasis-free survival (MFS) were examined using Kaplan Meier as well as univariate and multivariate Cox regression analyses in the whole cohort and in different molecular subtypes. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL96
461 Samples
Download data: CEL
Series
Accession:
GSE158309
ID:
200158309
19.

Affymetrix data for training of Endopredict algorithm

(Submitter supplied) These data, combined with other cohorts (GSE6532, GSE12093, and qRT-PCR based cohorts), was used to construct the EP algorithm, which predicts the likelihood of developing of a distant recurrence of early stage breast cancer under endocrine treatment. In addition, EPclin, a combination of the EP score, the nodal status and the tumor size, was constructed.
Organism:
Homo sapiens
Type:
Expression profiling by array; Third-party reanalysis
Platform:
GPL96
277 Samples
Download data: CEL, TXT
Series
Accession:
GSE26971
ID:
200026971
20.

Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis

(Submitter supplied) IL13Rα2 overexpression promotes metastasis of basal-like breast cancers IL13Rα2 depletion in highly metastatic breast cancer cells suppresses lung metastases formation by upregulating TP63 and decreasing their migratory potential
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL6244
8 Samples
Download data: CEL, CHP, TXT
Series
Accession:
GSE57677
ID:
200057677
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=1|qty=2|blobid=MCID_666c8e6c6e9d376f23365454|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center